Diabetic Nephropathies: all 544 studies
Page 4 of 6. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.
- Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic PatientStatus unknownNCT03859817
- Patient-Derived Stem Cell Therapy for Diabetic Kidney DiseaseTerminatedNCT03840343Phase 1
- Magnesium Supplementation in Diabetic NephropathyCompletedNCT03824379Phase 2
- Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic NephropathyStatus unknownNCT03820635
- Hypomagnesemia and Diabetic NephropathyCompletedNCT03690180
- the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKDCompletedNCT03681704Phase 1
- the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKDCompletedNCT03681249Early Phase 1
- Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)Status unknownNCT03664414Phase 4
- Renal Resisitive Index as an Indicator of the Progression of Diabetic NephropathyStatus unknownNCT03658317Not applicable
- Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving IrbesartanCompletedNCT03627715Phase 2
- Pentoxifylline in Diabetic Kidney DiseaseActive, not recruitingNCT03625648Phase 4
- Green Tea Extract on Soluble RAGE in Patients With Diabetic NephropathyStatus unknownNCT03622762Phase 2
- Association of BsmI Polymorphisms in Vitamin D Receptor Gene With Diabetic Kidney DiseaseCompletedNCT03621384
- Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 DiabetesCompletedNCT03620773Phase 1/2
- Vitamin B Complex and Diabetic Nephropathy in Type 1 DiabetesCompletedNCT03594240Phase 3
- T-regulatory Cells in Diabetic Type Two NephropathyStatus unknownNCT03591939
- Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic PatientsStatus unknownNCT03573102Phase 4
- A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME StudyTerminatedNCT03550443Phase 3
- Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney DiseaseStatus unknownNCT03535935Phase 2/3
- PeRsOnalising Treatment Of Diabetic Nephropathy:CompletedNCT03509454
- Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)WithdrawnNCT03504566Phase 4
- Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone TherapyStatus unknownNCT03502031Phase 4
- Relation of Epicardial Fat and Diabetic Nephropathy in Egyptian PatientsStatus unknownNCT03470415
- Extracorporeal Low-intensity Shockwave in Diabetic NephropathyStatus unknownNCT03445247Not applicable
- Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD)Status unknownNCT03415074Not applicable
- Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in SingaporeStatus unknownNCT03413215Not applicable
- A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney DiseaseCompletedNCT03412006Phase 2
- SWIDINEP a Swiss Diabetic Nephropathy CohortStatus unknownNCT03407989
- PERL Continuous Glucose Monitoring (CGM) StudyCompletedNCT03334318
- Inflammation and Stem Cells in Diabetic and Chronic Kidney DiseaseSuspendedNCT03325322Phase 2
- Use of Wharton Jelly in Diabetic NephropathyStatus unknownNCT03288571Phase 1/2
- Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.Status unknownNCT03284996
- Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic NephropathyStatus unknownNCT03262363Phase 2/3
- The Study of the Internet Monitoring and Analysis of Exercise to Reduce the Complications of Diabetic Kidney DiseaseStatus unknownNCT03222726Not applicable
- An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 DiabetesStatus unknownNCT03216564Phase 3
- Serum Immunoglobulin (G) as a Marker of Diabetic NephropathyStatus unknownNCT03212755Not applicable
- Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney DiseaseStatus unknownNCT03201406
- Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 DiabetesTerminatedNCT03184662Not applicable
- Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic NephropathyStatus unknownNCT03178253
- Effect Insulin Pump Therapy to Patients With Diabetic NephropathyCompletedNCT03174821Not applicable
- Empaglifozin in Early Diabetic Kidney DiseaseWithdrawnNCT03173963Phase 3
- This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are ToleratedCompletedNCT03165240Phase 1
- This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)CompletedNCT03165227Phase 1
- Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney DiseaseCompletedNCT03164785Phase 2/3
- PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic NephropathyCompletedNCT03155087
- Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.CompletedNCT03154398
- Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic NephropathyCompletedNCT03137316
- IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart DiseaseWithdrawnNCT03105219Phase 3
- EMPRA (EMPagliflozin and RAs in Kidney Disease)CompletedNCT03078101Phase 2
- Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney DiseaseStatus unknownNCT03016832Early Phase 1
- The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early StageStatus unknownNCT03009864Early Phase 1
- Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With NephropathyCompletedNCT03006952Phase 4
- Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus PatientsCompletedNCT02996539
- Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 DiabetesCompletedNCT02928250Not applicable
- Exercise Study Testing Enhanced Energetics of Mitochondria Video Integrated Delivery of Activity Training in CKDCompletedNCT02923063Not applicable
- Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 DiabetesCompletedNCT02914691Phase 4
- Microalbuminuria and Allopurinol in Type 1 DiabetesCompletedNCT02829177Phase 4
- CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep ApneaCompletedNCT02816762Phase 4
- Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?CompletedNCT02768948Not applicable
- Resveratrol's Effects in Diabetic NephropathyCompletedNCT02704494Early Phase 1
- Effect of Exenatide on 24h-UAER in Patients With Diabetic NephropathyCompletedNCT02690883Phase 4
- Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic NephropathyCompletedNCT02689778Phase 3
- An Extended Treatment Study of MT-3995 in Patients With Diabetic NephropathyCompletedNCT02676401Phase 2
- Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic PatientsCompletedNCT02625649
- NEPHSTROM for Diabetic Kidney DiseaseTerminatedNCT02585622Phase 1/2
- A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral NeuropathyCompletedNCT02552277Phase 2
- Antiproteinuric Effects of Liraglutide TreatmentCompletedNCT02545738Phase 4
- Efficacy and Safety of MT-3995 in Patients With Diabetic NephropathyCompletedNCT02517320Phase 2
- Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney DiseaseStatus unknownNCT02515461Not applicable
- The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic NephropathyStatus unknownNCT02501772Not applicable
- Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic NephropathyStatus unknownNCT02488252Phase 2/3
- Ayurvedic Management of Chronic Kidney DiseaseCompletedNCT02477163Not applicable
- Colchicine for Diabetic Nephropathy TrialStatus unknownNCT02442921Phase 1/2
- Integrated Population Program for Diabetic Kidney DiseaseCompletedNCT02418091Not applicable
- Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With MacroalbuminuriaWithdrawnNCT02410499Phase 2
- Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)TerminatedNCT02410005Phase 2/3
- Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)Status unknownNCT02409511
- Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy PatientsCompletedNCT02384902Not applicable
- A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With MicroalbuminuriaCompletedNCT02345057Phase 2
- Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without GoutCompletedNCT02327754Phase 2
- Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari PopulationCompletedNCT02316522
- Measurement of Endothelial Function and Cardiac Output: New MethodsCompletedNCT02299960
- Effect of LIXIsenatide on the Renal SystemCompletedNCT02276196Phase 4
- Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy PatientsCompletedNCT02251067Phase 2
- Mechanisms of Diabetic Nephropathy in EcuadorSuspendedNCT02237352
- Effect of Magnesium Supplementation on Patients With Diabetic NephropathyStatus unknownNCT02220036Not applicable
- Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic NephropathyCompletedNCT02205372Phase 1/2
- The Significance of Urine UbA52 In the Diagnosis of Diabetic NephropathyCompletedNCT02204280
- Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.CompletedNCT02194790Not applicable
- Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)CompletedNCT02176278Not applicable
- Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic ChildrenCompletedNCT02164279
- Pyridorin in Diabetic NephropathyTerminatedNCT02156843Phase 3
- The Differential Effects of Diabetes Therapy on InflammationCompletedNCT02150707
- Metabolomic Profiling in Adolescents With Obesity and DiabetesCompletedNCT02145572
- Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.CompletedNCT02112071Not applicable
- Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With NormoalbuminuriaCompletedNCT02040441Phase 2/3
- Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and MicroalbuminuriaStatus unknownNCT02035891Not applicable
- Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best MedicineWithdrawnNCT02011178Not applicable
- The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male VolunteerCompletedNCT02004327Phase 1
- Arterial Stiffness and Complication Risk in Type 2 DiabetesCompletedNCT02001532